VERV - Verve Therapeutics, Inc.
Price:
--
--
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue | 32.3 | 11.8 | 1.9 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 3.4 | 1.3 | 0.1 |
| Gross Profit | 32.3 | 11.8 | 1.9 | (3.4) | (1.3) | (0.1) |
| Operating Expenses | ||||||
| R&D Expenses | 204.3 | 184.9 | 130.1 | 68.2 | 35.4 | 11.1 |
| SG&A Expenses | 56.6 | 49.9 | 37.5 | 18.9 | 5.3 | 2.5 |
| Other Expenses | 0 | 0 | 1.5 | (33.4) | (5.2) | 0 |
| Operating Expenses | 261.0 | 234.9 | 167.6 | 87.1 | 40.6 | 13.6 |
| Operating Income | ||||||
| Operating Income | (228.7) | (223.1) | (165.7) | (87.1) | (40.6) | (13.6) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 28.8 | 23.2 | 6.9 | 0.1 | 0.2 | 0.3 |
| Profitability | ||||||
| EBITDA | (221.9) | (217.7) | (162.9) | (85.5) | (39.3) | (13.5) |
| EBIT | (228.7) | (223.1) | (165.7) | (120.3) | (40.6) | (13.6) |
| Income Before Tax | (198.4) | (199.8) | (157.3) | (120.3) | (45.7) | (19.3) |
| Income Tax Expense | 0.3 | 0.3 | 0.1 | 0 | 0 | 0 |
| Net Income | (198.7) | (200.1) | (157.4) | (118.6) | (45.5) | (19.0) |
| Per Share Data | ||||||
| EPS (Basic) | -2.36 | -3.12 | -2.91 | -2.45 | -0.94 | -0.65 |
| EPS (Diluted) | -2.35 | -3.12 | -2.91 | -2.45 | -0.94 | -0.65 |
| Shares Outstanding | 84.7 | 64.2 | 54.0 | 48.5 | 48.2 | 29.2 |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | 172.6 | 206.2 | 115.4 | 64.3 | 9.0 | 3.0 |
| Short-Term Investments | 351.7 | 417.8 | 439.4 | 296.1 | 63.1 | 15.8 |
| Net Receivables | 3.3 | 5.9 | 1.0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 15.2 | 8.1 | 7.3 | 6.7 | 0 | 0 |
| Total Current Assets | 542.8 | 637.9 | 563.2 | 367.1 | 74.0 | 19.1 |
| Non-Current Assets | ||||||
| Property, Plant & Equipment | 96.7 | 107.8 | 110.7 | 9.1 | 4.0 | 2.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 4.8 | 4.8 | 4.8 | 5.2 | 0.5 | 0.2 |
| Other Non-Current Assets | 7.9 | 6.9 | 0.6 | 2.7 | 0 | 0 |
| Total Non-Current Assets | 104.6 | 114.7 | 116.1 | 17.0 | 4.4 | 2.6 |
| Total Assets | 647.4 | 752.7 | 679.2 | 384.1 | 78.4 | 21.6 |
| Current Liabilities | ||||||
| Account Payables | 4.5 | 6.6 | 2.4 | 7.1 | 0.0 | 2.4 |
| Short-Term Debt | 0 | 0 | 11.9 | 2.0 | 0 | 0 |
| Deferred Revenue | 3.6 | 0 | 20.0 | (13.0) | 0.1 | 0.0 |
| Other Current Liabilities | 14.3 | 12.3 | (0.3) | 5.0 | 0 | 0.5 |
| Total Current Liabilities | 42.9 | 37.0 | 35.1 | 22.0 | 7.3 | 3.6 |
| Non-Current Liabilities | ||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 125.2 | 35.1 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.3 | 2.9 | 3.2 | 4.7 | 9.7 | 2.5 |
| Total Non-Current Liabilities | 111.1 | 116.2 | 93.2 | 4.7 | 135.0 | 37.6 |
| Total Liabilities | 154.0 | 153.2 | 128.3 | 26.8 | 142.3 | 41.2 |
| Stockholders' Equity | ||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (743.0) | (544.3) | (344.2) | (186.8) | (66.5) | (20.8) |
| Accumulated Other Comprehensive Income | 0.4 | 0.3 | (0.7) | (0.2) | 0.0 | 0.0 |
| Total Stockholders' Equity | 493.4 | 599.5 | 550.9 | 357.4 | (63.9) | (19.6) |
| Total Liabilities & Equity | 647.4 | 752.7 | 679.2 | 384.1 | 78.4 | 21.6 |
| Debt Metrics | ||||||
| Total Debt | 70.0 | 74.9 | 81.9 | 2.0 | 125.2 | 35.1 |
| Net Debt | (102.6) | (131.3) | (33.5) | (62.4) | 116.2 | 32.1 |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | (198.7) | (200.1) | (157.4) | (120.3) | (45.7) | (19.3) |
| Depreciation & Amortization | 6.8 | 5.5 | 2.8 | 1.5 | 1.3 | 0.1 |
| Stock-Based Compensation | 43.3 | 35.1 | 22.5 | 7.1 | 0.8 | 0.4 |
| Change in Working Capital | (2.3) | 17.7 | 8.4 | (2.9) | 2.6 | 2.7 |
| Other Non-Cash Items | (6.7) | (7.8) | 1.4 | 35.2 | 5.2 | 8.7 |
| Operating Cash Flow | (157.7) | (149.5) | (122.3) | (77.9) | (35.3) | (7.4) |
| Investing Activities | ||||||
| Capital Expenditure | (3.7) | (9.3) | (13.2) | (4.4) | (3.4) | (1.9) |
| Acquisitions | 0 | 0 | 142.7 | 234.7 | 47.7 | 10.9 |
| Purchases of Investments | (424.0) | (517.1) | (479.4) | (371.5) | (98.5) | (22.0) |
| Sales/Maturities of Investments | 502.6 | 554.1 | 336.7 | 136.8 | 50.8 | 11.1 |
| Other Investing Activities | 0 | 0 | (142.7) | (234.7) | (47.7) | (10.9) |
| Investing Cash Flow | 74.9 | 27.7 | (156.0) | (239.1) | (51.1) | (12.8) |
| Financing Activities | ||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.5 | 2.1 | 2.5 | (1.9) | 0.0 | (0.1) |
| Financing Cash Flow | 49.2 | 212.6 | 329.0 | 377.1 | 92.6 | 18.0 |
| Cash Position | ||||||
| Net Change in Cash | (33.6) | 90.7 | 50.7 | 60.1 | 6.2 | (2.2) |
| Cash at Beginning | 211.0 | 120.2 | 69.6 | 9.5 | 3.2 | 5.5 |
| Cash at End | 177.3 | 211.0 | 120.2 | 69.6 | 9.5 | 3.2 |
| Free Cash Flow | (161.4) | (158.8) | (135.6) | (82.2) | (38.7) | (9.3) |
| Key Metrics | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 32.3 | 11.8 | 1.9 | 0 | 0 | 0 |
| Gross Profit | 32.3 | 11.8 | 1.9 | (3.4) | (1.3) | (0.1) |
| Operating Income | (228.7) | (223.1) | (165.7) | (87.1) | (40.6) | (13.6) |
| Net Income | (198.7) | (200.1) | (157.4) | (118.6) | (45.5) | (19.0) |
| EPS (Diluted) | -2.35 | -3.12 | -2.91 | -2.45 | -0.94 | -0.65 |
| Balance Sheet | ||||||
| Cash & Equivalents | 172.6 | 206.2 | 115.4 | 64.3 | 9.0 | 3.0 |
| Total Assets | 647.4 | 752.7 | 679.2 | 384.1 | 78.4 | 21.6 |
| Total Debt | 70.0 | 74.9 | 81.9 | 2.0 | 125.2 | 35.1 |
| Stockholders' Equity | 493.4 | 599.5 | 550.9 | 357.4 | (63.9) | (19.6) |
| Cash Flow | ||||||
| Operating Cash Flow | (157.7) | (149.5) | (122.3) | (77.9) | (35.3) | (7.4) |
| Capital Expenditure | (3.7) | (9.3) | (13.2) | (4.4) | (3.4) | (1.9) |
| Free Cash Flow | (161.4) | (158.8) | (135.6) | (82.2) | (38.7) | (9.3) |